Prevention of mouse lung tumors by combinations of chemopreventive agents using concurrent and sequential administration

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3279-3284

  Casto, Bruce C ^a   Pereira, Michael A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemoprevention; Combined treatment; Lung cancer; Mouse model

Indexed keywords

4 METHYLNITROSOAMINO LEVO 2 PYRIDYL LEVO BUTANOL; ATORVASTATIN; BEXAROTENE; BUDESONIDE; CARCINOGEN; UNCLASSIFIED DRUG; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; LUNG TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; BUDESONIDE; CHEMOPREVENTION; FEMALE; HYDROXAMIC ACIDS; LUNG NEOPLASMS; MICE; TETRAHYDRONAPHTHALENES;

EID: 80054718842     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Cancer Society: Cancer Facts & Figures 2010. Atlanta: American Cancer Society, 2010.
2. Ip C: Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. Cancer Lett 39: 239-246, 1988.
3. Zhang Q, Fu H, Pan J, He J, Ryota S, Hara Y, Wang Y, Lubet RA and You M: Effect of dietary polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Pharm Res 27: 1066-1071, 2010.
4. el-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hoffmann D and Wynder EL: Effects of 1,4-phenylenebis(methylene) selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 16: 2709-2712, 1996. (Pubitemid 26388241)
5. Witschi H, Espiritu I and Uyeminami D: Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis 20: 1375-1378, 1999. (Pubitemid 29341464)
6. Estensen RD and Wattenberg LW: Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis 14: 1975-1977, 1993. (Pubitemid 23290920)
7. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE and Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 21: 179-182, 2000. (Pubitemid 30098700)
8. Alyaqoub FS, Tao L, Kramer PM, Steele VE, Lubet RA, Gunning WT and Pereira MA: Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with Budesonide and R115777 (Zamestra MT). Carcinogenesis 28: 124-129, 2007. (Pubitemid 44942635)
9. D'Agostini F, Balansky RM, Camoirano A and de Flora S: Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis. Int J Cancer 88: 702-707, 2000.
10. Hecht SS, Upadhyaya P, Wang M, Bliss RL, McIntee EJ and Kenney PM: Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2- phenethylthiocarbamoyl)-L-cysteine and myoinositol, individually and in combination. Carcinogenesis 23: 1455-1461, 2002. (Pubitemid 35021225)
11. Kassie F, Melkamu T, Endalew A, Upadhyaya P, Luo X and Hecht SS: Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-1-cysteine, indole-3-carbinol and myo-inositol, alone and in combination. Carcinogenesis 31: 1634-1641, 2010.
12. Pereira MA, Li Y, Gunning WT, Kramer PM, Al-Yaqoub F, Lubet RA, Steele VE, Szabo E and Tao L: Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 23: 1185-1192, 2002. (Pubitemid 34814777)
13. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE and Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57: 5489-5492, 1997. (Pubitemid 28006753)
14. Wang Y, Zhang Z, Kastens E, Lubet RA and You M: Mice with alteration in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 63: 4389-4395, 2003. (Pubitemid 36951008)
15. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW and Kelloff GJ: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program. Cellular Biochem Suppl 20: 32-54, 1994.
16. Pereira MA, Kramer PM, Nines R, Liu Y, Alyaqoub FS, Gunning WT, Steele VE and Lubet RA: Prevention of mouse lung tumors by targretin. Int J Cancer 118: 2359-2362, 2006.
17. Lubet RA, Christov K, Numez NP, Hursting SD, Steele VE, Juliana MM, Eto I and Grubbs CJ: Efficacy of Targretin on methylnitrosourea-induced mammary cancers: Prevention and therapy dose response curves and effects on proliferation and apoptosis. Carcinogenesis 26: 441-448, 2005. (Pubitemid 40246566)
18. Alyaqoub FS, Liu Y, Tao L, Steele VE, Lubet RA and Pereira MA: Modulation by bexarotene of mRNA expression of genes in mouse lung tumors. Mol Carcinog 47: 165-171, 2008. (Pubitemid 351398061)
19. Cohen LA, Amin S, Marks PA, Rifkind RA, Desai D and Richon VM: Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res 19: 4999-5005, 1999. (Pubitemid 30103315)
20. Cohen LA, Marks PA, Rifkind RA, Amin S, Desai D, Pittman B and Richon VM: Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. Anticancer Res 22: 1497-1504, 2002. (Pubitemid 34839156)
21. Desai D, Das A, Cohen L, el-Bayoumy K and Amin S: Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino) -1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Anticancer Res 23: 499-503, 2003. (Pubitemid 36358560)
22. Hoffmeister M, Chang-Claude J and Brenner H: Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer 121: 1325-1330, 2007. (Pubitemid 47293801)
23. Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP Jr., Sternfeld B, Jacobsen SJ, Whitmer RA and Caan BJ: Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 16: 2218-2225, 2007. (Pubitemid 351196352)
24. Lu G, Xiao H, You H, Lin Y, Jin H, Snagaski B and Yang CS: Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res 14: 4981-4988, 2008.